RASSF4 and cancer: In various malignant tumors, the CpG islands enriched in the 5′ promoter region of the RASSF4 gene often undergo abnormal methylation modifications, a process primarily mediated by DNA methyltransferases 1 (DNMT1) and DNMT3A/B [61,62], leading to transcriptional silencing of the gene.